Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 213-215

  Ho, C M L ^a,c   Vowels, M R ^a   Lockwood, L ^b   Ziegler, J B ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

Bone marrow transplant; Bowel obstruction; Chronic granulomatous disease; Veno occlusive disease

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE; NITROBLUE TETRAZOLIUM; THYMOCYTE ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CONSERVATIVE TREATMENT; MALE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; SMALL INTESTINE OBSTRUCTION;

BONE MARROW TRANSPLANTATION; GRANULOMATOUS DISEASE, CHRONIC; HEPATIC VENO-OCCLUSIVE DISEASE; HISTOCOMPATIBILITY; HUMANS; INFANT; INTESTINAL OBSTRUCTION; MALE; NUCLEAR FAMILY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; X CHROMOSOME;

EID: 0029759477     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Babior BM, Woodman RC. Chronic granulomatous disease. Semin Hematol 1990; 27: 247-259.
2. Mouy R, Fischer A, Vilmer E et al. Incidence, severity, prevention of infection in CGD. J Pediatr 1989; 114: 555-560.
3. The International CGD cooperative study group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. New Engl J Med 1991; 324: 509-516.
4. Ezekowitz RAB, Dinauer MC, Jaffe HS et al. Partial correction of the phagocyte defect in patients with X-linked CGD by subcutaneous interferon gamma. New Engl J Med 1988; 319: 146-151.
5. Lucarelli G, Galimberti M, Polchi P et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. New Engl J Med 1993; 329: 840-844.
6. Shaw PJ, Hugh-Jones K, Hobbs JR et al. Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in 50 children. Bone Marrow Transplant 1986; 1: 193-200.
7. Goudemand J, Aussens R, Delmas-Marsalel Y et al. Attempt to treat a case of chronic familial granulomatous disease by allogeneic bone marrow transplantation. Arch Fr Pediat 1976; 33: 121-126.
8. Westminster Hospitals Bone Marrow Transplant Team. Bone marrow transplant from an unrelated donor for chronic granulomatous disease. Lancet 1977; 1: 210-213.
9. Rappeport JM, Newburger PE, Goldblum RM et al. Allogeneic bone marrow transplantation for chronic granulomatous disease. J Pediatr 1982; 101: 952-955.
10. Kamani N, August CS, Douglas SD et al. Bone marrow transplantation in chronic granulomatous disease. J Pediatr 1984; 105: 42-46.
11. Kamani N, August CS, Campbell DE et al. Marrow transplantation in chronic granulomatous disease: an update with 6-year follow-up. J Pediatr 1988; 113: 697-700.
12. Di Bartolomeo P, Di Girolamo G, Angrilli F et al. Reconstitution of normal neutrophil function in chronic granulomatous disease by bone marrow transplantation. Bone Marrow Transplant 1989; 4: 695-700.
13. Bearman SI, Shuhart MC, Hinds MS, McDonald GB. Recombinant human tissue plasminogen activator for the treatment of established severe veno-occlusive disease of the liver after BMT. Blood 1992; 80: 2458-2462.
14. Rosenthal J, Sender L, Montes V et al. Safety and efficacy of heparin prophylaxis and tissue plasminogen activator (TPA) treatment for veno-occlusive disease of the liver in children following bone marrow transplant. Blood 1993; 82: 1623 (Abstr.).
15. Yu LC, Malkani I, Regueira O et al. Recombinant tissue plasminogen activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients. Am J Haematol 1994; 46: 194-198.
16. Baglin P, Harper P, Marcus RE. Veno-occlusive disease of liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA). Bone Marrow Transplant 1990; 5: 439-441.
17. Lacatelli F, Uderzo C, Dini G et al. Graft-versus-host disease in children: the AIEOP-BMT group experience with cyclosporin A. Bone Marrow Transplant 1993; 12: 627-633.